Neuropace, Inc. NPCE Unrealized Gains on Investments
Unrealized Gains on Investments at other companies
Other financials
Where this comes from
Reported directly by Neuropace, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax.
The official record: Neuropace, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Neuropace, Inc.'s unrealized gains on investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Neuropace, Inc.'s unrealized gains on investments?
- Neuropace, Inc. (NPCE) reported unrealized gains on investments of $0 in Q1 2026.
- How has Neuropace, Inc.'s unrealized gains on investments changed year-over-year?
- Neuropace, Inc.'s unrealized gains on investments decreased by 100.0% year-over-year, from $100K to $0.
- What is the long-term trend for Neuropace, Inc.'s unrealized gains on investments?
- Over 4 years (2020 to 2025), Neuropace, Inc.'s unrealized gains on investments has grown at a 56.9% compound annual growth rate (CAGR), from $33K to $200K.
- What does unrealized gains on investments mean?
- This reflects the increase in the fair market value of investment securities held by the company that have not yet been sold. It represents paper gains that fluctuate based on market conditions rather than operational performance. Tracking this provides insight into the company's treasury management and the performance of its non-operating asset portfolio.